Table 5.
Univariate survival analysis: progression rate in low- and high-risk groups of sCr, proteinuric, and histologic parameters defined according to a cutoff with the highest sensitivity and specificity for progression (all patients independently from treatment)a
| Risk Factors | Progression | P |
|---|---|---|
| sCr < versus ≥1.74 (20 versus 14) | 5 versus 71% | <0.0001 |
| FEIgG/SG < versus ≥0.00034 (22 versus 12) | 5 versus 83% | <0.0001 |
| FEα1m/SG < versus ≥0.04 (21 versus 13) | 5 versus 77% | <0.0001 |
| TID score < versus ≥3 (13 versus 21) | 0 versus 52% | 0.0059 |
| GGS < versus ≥20% (18 versus 16) | 11 versus 56% | 0.0157 |
| uα2m/g uCr/SG < versus ≥0.11 (24 versus 10) | 12 versus 80% | 0.0003 |
| 24hP/SG < versus ≥0.034 (24 versus 10) | 11 versus 56% | 0.0100 |
| Cellular crescents < versus ≥17% (17 versus 17) | 24 versus 41% | 0.2580 |
a
Numbers in parentheses are the number of patients of the low- and high-risk groups, respectively.